MedTrace Logo

A Trial of HRF2105 Patch in Relieving Pain of Osteoarthritis

NCT06047483 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2023-09-21

No results posted yet for this study

Summary

The study is being conducted to evaluate the efficacy, and safety of HRF2105patch in relieving pain of Osteoarthritis.

Conditions

  • Analgesia and Anti-inflammatory of Osteoarthritis

Interventions

DRUG

HRF2105 patch

HRF2105 patch ，external use，once a day

DRUG

Loxoprofen patch

Loxoprofen patch ，external use，once a day

DRUG

placebo

placebo ，external use，once a day

Sponsors & Collaborators

  • Jiangsu HengRui Medicine Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-31
Primary Completion
2023-12-31
Completion
2023-12-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06047483 on ClinicalTrials.gov